Rh Family A Glycoprotein (RHAG) Peptide
-
- Target See all RHAG products
- RHAG (Rh Family A Glycoprotein (RHAG))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FGAVLGKTSP TQMLIMTILE IVFFAHNEYL VSEIFKASDI GASMTIHAFG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RHAG antibody,
Alternative Names: RHAG control peptide, RHAG antibody Blocking Peptide, Anti-RHAG Blocking Peptide, Rh-Associated Glycoprotein Blocking Peptide, RH2 Blocking Peptide, RH50A Blocking Peptide, Rh50 Blocking Peptide, Rh50 GP Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- RHAG (Rh Family A Glycoprotein (RHAG))
- Background
- The Rh blood group antigens are associated with human erythrocyte membrane proteins of approximately 30 kDa, the so-called Rh30 polypeptides. Heterogeneously glycosylated membrane proteins of 50 and 45 kDa, the Rh50 glycoproteins, are coprecipitated with the Rh30 polypeptides on immunoprecipitation with anti-Rh-specific mono- and polyclonal antibodies. The Rh antigens appear to exist as a multisubunit complex of CD47, LW, glycophorin B, and play a critical role in the Rh50 glycoprotein.
- Molecular Weight
- 45 kDa
-